Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v7-FR
Language French French
Date Updated 2023-08-08 2022-12-19
Drug Identification Number 02468689 02468689
Brand name AURO-CEFIXIME AURO-CEFIXIME
Common or Proper name CEFIXIME CEFIXIME
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients CEFIXIME CEFIXIME
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 50ml 50ml
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-12 2022-08-12
Estimated end date 2023-09-01 2023-01-12
Actual end date 2023-07-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments